retatrutide weight loss clinical trial results 2024 2025 press release Lilly's retatrutide shows 28% weight loss Difference between tirzepatide and retatrutide:
Description
Originally designed to treat Type 2 diabetes, many people are now using them for weight management and other metabolic health concerns
The data comes from the Phase 2 SURMOUNT trial involving 338 participants across all dose groups, with the most comprehensive data available for the 12mg maintenance dose
Novos American depositary receipts gained 5.1% at 1:10 p.m
32 Navigating the payer and reimbursement terrain In the American context, clinical success is a prerequisite, but the J-code is destiny
